Is The Downturn A ‘Darwinian Moment’ For Biotech? The View From The Frontline
Cutbacks And Threat Of Closure Hitting Small To Medium Biotechs
After the boom of 2020 and 2021, the biotech sector is experiencing one of the deepest and longest downturns but there are hopes that catalysts could soon revive confidence.
